A+
|
A
|
A-
|
Skip to main content
|
IPO
LOGIN
OPEN A DEMAT ACCOUNT
IPO
Login
Open a
Demat
Account
HOME
ABOUT US
PRODUCTS
Equity
Currency
Commodity
IPO
Mutual Funds
PMS
SLBM
SERVICES
Investment Banking
Institutional Equities
Wealth Management
Depository
TRADE WITH SYSTEMATIX
Partner With Us
Trading Simplified
Payment Gateway
Link UPI
KYC Updation
ReKYC
(Document Reactivation/Modification in Account/Nominee Registration/Account Closure)
Bank Details
Account Opening Process
Incapacitated investor
RESEARCH
MARKETS
Overview
Equity
IPO
Mutual Funds
Commodity
Company Info
INVESTORS
Investor Login
Investor Relations
Investor Grievances
ODR
Scores
Downloads
Investor Charter
Information to Physical Shareholders
Procedure for Filing a Complaint
Investor Education
CONTACT US
Our Reach
Careers
OPEN A DEMAT ACCOUNT
HOME
ABOUT US
PRODUCTS
EQUITY
CURRENCY
COMMODITY
IPO
MUTUAL FUND
PMS
SLBM
SERVICES
INVESTMENT BANKING
INSTITUTIONAL EQUITIES
WEALTH MANAGEMENT
DEPOSITORY
TRADE WITH SYSTEMATIX
PARTNER WITH US
TRADING SIMPLIFIED
PAYMENT GATEWAY
LINK UPI
KYC UPDATION
ReKYC (Document Reactivation/Modification in Account/Nominee Registration/Account Closure)
BANK DETAILS
ACCOUNT OPENING PROCESS
Incapacitated investor
RESEARCH
MARKETS
OVERVIEW
EQUITY
IPO
MUTUAL FUND
COMMODITY
COMPANY INFO
INVESTORS
INVESTOR LOGIN
INVESTOR RELATIONS
INVESTOR GRIEVANCES
ODR
SCORES
DOWNLOADS
INVESTOR CHARTER
INFORMATION TO PHYSICAL SHAREHOLDERS
PROCEDURE FOR FILING A COMPLAINT
Investor Education
CONTACT US
OUR REACH
CAREERS
Equity
Mutual Fund
IPO Analysis
Daily Market Tracker
Gainers & Losers
Value & Volume Toppers
52 Week Highs & Lows
New Highs & Lows
Buyers & Sellers
Out/Under Performers
Bulk Deals
Block Deals
Unusual Volume
Rising Volume
Exchange Holidays
5 Days Up & Down
Index Movers
Index Overview
Top Sectors
News & Analysis
Pre Session Commentary
Mid Session Commentary
End Session Commentary
Quick Review
Market Beat
Stock Alert
Hot Pursuit
Foreign Markets
Economy News
Corporate News
Corporate Results
Other Markets
Futures Markets
Corporate Information
Company Snapshot
Company Background
Board Of Directors
Balance Sheet
Profit & Loss
Quarterly Results
Key Financial Ratios
Share Holding Pattern
Previous Quarter Comp
Director's Report
Score Board
Mutual Fund Holdings
Announcements
Peer Comparison
Technical Chart
Corporate Actions
Announcements
Book Closure
Board Meetings
Bonus Issues
Rights Issues
Delisted Shares
Market Turnover
Name Change
Split Of Face Value
Event Calendar
Other Markets
ADR Prices
FII Investments
MF Investments
Forex Details
World Indices
GDR Prices
Equity
Commodity
Mutual Fund
IPO
Price Analysis
Volume Analysis
News Analysis
Market Option
Other Option
Company Information
Gainers & Losers
52 Week High Low
News Highs and Low
Advances & Declines
Home
Market Info
Corporate Information
Company Snapshot
Company Snapshot
BSE
Krebs Biochemicals & Industries Ltd
BSE Code
524518
ISIN Demat
INE268B01013
Book Value (₹)
-74.60
Div & Yield %
0
Market Cap (
₹
Cr.)
115.39
P/E *
0
EPS *
0
Face Value (₹)
10
* Profit to Earning Ratio
* Earning Per Share
Stock Price Details
Last Price (₹)
57.08
Change
3.56 (6.65%)
Best Buy (₹)
52.00
Best Sell (₹)
57.00
Today's Range
57.08 - 57.08
52-Week Range
51.00 - 113.90
Beta (1 Year)
1.17
Chart
1 Day
|
5 Day
|
3 Month
|
1 Year
|
5 Year
Corporate Announcements
Krebs Biochemicals & Industries reports standalone net loss of Rs 3.13 crore in the December 2025 quarter
Krebs Biochemicals & Industries to hold board meeting
Krebs Biochemicals & Industries to conduct board meeting
Krebs Biochemicals & Industries reports standalone net loss of Rs 6.14 crore in the September 2025 quarter
Krebs Biochemicals & Industries to declare Quarterly Results
Krebs Biochemicals & Industries Ltd - Krebs Biochemicals and Industries Limited - Updates
Krebs Biochemicals & Industries Ltd - Report On Re-Lodgement Of Transfer Requests Of Physical Shares
Krebs Biochemicals & Industries Ltd - Krebs Biochemicals and Industries Limited - Shareholders meeting
Krebs Biochemicals & Industries Ltd - Shareholder Meeting / Postal Ballot-Scrutinizers Report
Krebs Biochemicals & Industries Ltd - Shareholder Meeting / Postal Ballot-Outcome of AGM
Corporate Details
Incorporation Year :
1991
Chairman :
R T Ravi
Ownership Group :
Indian Private
Sector :
Pharmaceuticals
Industry :
Pharmaceuticals - Indian - Bulk Drugs
Registered Office :
Krebs Biochemicals & Industries Ltd
Kothapalli(V) Kasimkota(M),
Anakapalli,
Vishakapatnam,
Andhra Pradesh - 531031,
Phone : 91-040-6680 8040,
Fax : N.A.
E-Mail :
investors@krebsbiochem.com; avinashr@krebsbiochem.
URL :
http://www.krebsbiochem.com
Investor Returns
Period
Date
Price
Returns (%)
1Week
23-Feb-2026
59.25
-9.67
1Month
02-Feb-2026
58.00
-7.72
3Month
03-Dec-2025
64.37
-16.86
6Month
03-Sep-2025
74.02
-27.70
1Year
03-Mar-2025
81.90
-34.65
Mutual Funds Holding
Scheme Name
% Holding
Market Value
No Data Found
Peerset : Pharmaceuticals - Indian - Bulk Drugs
Company
Last Price (₹)
Change (%)
52Week High (₹)
52Week Low (₹)
Market Cap (₹ Cr.)
Divis Laboratories Ltd
6,291.00
-1.75
7,077.70
4,941.70
169,988.82
Acutaas Chemicals Ltd
2,109.65
-3.72
2,200.00
930.03
17,939.60
Neuland Laboratories Ltd
12,888.00
-1.59
19,748.40
10,060.00
16,801.77
Jubilant Pharmova Ltd
828.00
-2.45
1,250.00
820.05
13,521.38
Dishman Pharmaceuticals and Chemicals Ltd(Merged)
301.05
0.00
0.00
0.00
4,858.77
Index Details